321 related articles for article (PubMed ID: 2984449)
21. The acute effect of angiotensin II on adrenal and anterior pituitary function in normal subjects and subjects with primary hyperaldosteronism.
Fraser R; Mason PA; Young J
Prog Biochem Pharmacol; 1980; 17():14-9. PubMed ID: 6259651
[TBL] [Abstract][Full Text] [Related]
22. Effects of corticotropin-releasing factor (CRF) on aldosterone and 18-hydroxycorticosterone in essential hypertension and primary aldosteronism.
Miyamori I; Yasuhara S; Matsubara T; Okamoto S; Ikeda M; Koshida H; Morise T; Takeda Y; Takeda R; Vecsei P
Endocrinol Jpn; 1987 Dec; 34(6):809-19. PubMed ID: 2836182
[TBL] [Abstract][Full Text] [Related]
23. Somatostatin suppresses plasma aldosterone concentration in a case of Bartter's syndrome.
Shigeta H; Tasaki N; Kitazumi S; Kitagawa Y; Nakano K; Kanatsuna T; Kondo M
Endocrinol Jpn; 1987 Apr; 34(2):309-12. PubMed ID: 2887425
[TBL] [Abstract][Full Text] [Related]
24. Circadian rhythm of plasma aldosterone concentration in patients with primary aldosteronism.
Kem DC; Weinberger MH; Gomez-Sanchez C; Kramer NJ; Lerman R; Furuyama S; Nugent CA
J Clin Invest; 1973 Sep; 52(9):2272-7. PubMed ID: 4353776
[TBL] [Abstract][Full Text] [Related]
25. Aldosterone and its stimuli in normal and hypertensive man: are essential hypertension and primary hyperaldosteronism without tumour the same condition?
Davies DL; Beevers DG; Brown JJ; Cumming AM; Fraser R; Lever AF; Mason PA; Morton JJ; Robertson JI; Titterington M; Tree M
J Endocrinol; 1979 May; 81(2):79P-91P. PubMed ID: 458346
[No Abstract] [Full Text] [Related]
26. Effect of oral glucose loading on plasma insulin, potassium, renin and aldosterone in normal subjects and patients with primary hyperaldosteronism.
Beretta-Piccoli C; Weidmann P; Bianchetti MG; Brown JJ; Fraser R; Lever AF; Link L; Robertson JI
Clin Exp Hypertens A; 1982; 4(9-10):1541-58. PubMed ID: 6754145
[TBL] [Abstract][Full Text] [Related]
27. Stress-induced Aldosterone Hyper-Secretion in a Substantial Subset of Patients With Essential Hypertension.
Markou A; Sertedaki A; Kaltsas G; Androulakis II; Marakaki C; Pappa T; Gouli A; Papanastasiou L; Fountoulakis S; Zacharoulis A; Karavidas A; Ragkou D; Charmandari E; Chrousos GP; Piaditis GP
J Clin Endocrinol Metab; 2015 Aug; 100(8):2857-64. PubMed ID: 25974737
[TBL] [Abstract][Full Text] [Related]
28. Effect of bromocriptine treatment on the aldosterone response to angiotensin II and adrenocorticotropin in idiopathic hyperaldosteronism.
Wisgerhof M; Mellinger RC
J Clin Endocrinol Metab; 1985 Jul; 61(1):192-5. PubMed ID: 2987293
[TBL] [Abstract][Full Text] [Related]
29. [Renin and aldosterone].
Salvetti A; Acquaviva G; Sassano P; Arzilli F
Ann Ist Super Sanita; 1975; 11(1-2):72-97. PubMed ID: 1232875
[TBL] [Abstract][Full Text] [Related]
30. Effect of corticotropin on aldosterone excretion and plasma renin in normal subjects, in essential hypertension and in primary aldosteronism.
Newton MA; Laragh JH
J Clin Endocrinol Metab; 1968 Jul; 28(7):1006-13. PubMed ID: 4298942
[No Abstract] [Full Text] [Related]
31. Adrenal steroid responses to ACTH in glucocorticoid-suppressible aldosteronism.
Ganguly A; Weinberger MH; Guthrie GP; Fineberg NS
Hypertension; 1984; 6(4):563-7. PubMed ID: 6086520
[TBL] [Abstract][Full Text] [Related]
32. The constant plasma 18-hydroxycorticosterone to aldosterone ratio: an expression of the efficacy of corticosterone methyloxidase type II activity in disorders with variable aldosterone production.
Kater CE; Biglieri EG; Rost CR; Schambelan M; Hirai J; Chang BC; Brust N
J Clin Endocrinol Metab; 1985 Feb; 60(2):225-8. PubMed ID: 2981240
[TBL] [Abstract][Full Text] [Related]
33. Increased adrenal sensitivity to angiotensin II in idiopathic hyperaldosteronism.
Wisgerhof M; Carpenter PC; Brown RD
J Clin Endocrinol Metab; 1978 Nov; 47(5):938-43. PubMed ID: 400738
[TBL] [Abstract][Full Text] [Related]
34. Hypertension corrected and aldosterone responsiveness to renin-angiotensin restored by long-term dexamethasone in glucocorticoid-suppressible hyperaldosteronism.
Woodland E; Tunny TJ; Hamlet SM; Gordon RD
Clin Exp Pharmacol Physiol; 1985; 12(3):245-8. PubMed ID: 2992855
[TBL] [Abstract][Full Text] [Related]
35. Effect of naloxone on the adrenal cortex in primary aldosteronism.
Fallo F; Boscaro M; Sonino N; Mantero F
Am J Hypertens; 1988 Jul; 1(3 Pt 1):280-2. PubMed ID: 2839206
[TBL] [Abstract][Full Text] [Related]
36. Arterial blood pressure and plasma and body electrolytes in idiopathic hyperaldosteronism: a comparison with primary hyperaldosteronism (Conn's syndrome) and essential hypertension.
Lasaridis A; Brown JJ; Davies DL; Fraser R; Robertson JI; Lever AF
J Hypertens; 1984 Aug; 2(4):329-36. PubMed ID: 6530544
[TBL] [Abstract][Full Text] [Related]
37. Effects of naloxone on the pituitary-adrenal axis in patients with dexamethasone-suppressible hyperaldosteronism.
Fallo F; Boscaro M; Sonino N; Mantero F
Clin Endocrinol (Oxf); 1987 Feb; 26(2):163-8. PubMed ID: 2822294
[TBL] [Abstract][Full Text] [Related]
38. Cortisol Co-Secretion and Clinical Usefulness of ACTH Stimulation Test in Primary Aldosteronism: A Systematic Review and Biases in Epidemiological Studies.
Inoue K; Kitamoto T; Tsurutani Y; Saito J; Omura M; Nishikawa T
Front Endocrinol (Lausanne); 2021; 12():645488. PubMed ID: 33796078
[TBL] [Abstract][Full Text] [Related]
39. Rhythm characteristics of plasma renin, aldosterone and cortisol in five subtypes of mesor-hypertension.
Cugini P; Manconi R; Serdoz R; Mancini A; Meucci T; Scavo D
J Endocrinol Invest; 1980; 3(2):143-7. PubMed ID: 6248590
[TBL] [Abstract][Full Text] [Related]
40. [Plasma-aldosterone and renin activity in Bartter's syndrome (author's transl)].
Rössler R
Dtsch Med Wochenschr; 1975 Nov; 100(47):2443-8. PubMed ID: 171132
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
